Bottom line
PILL vs TMV: the short answer
PILL (Direxion Daily Pharmaceutical & Medical Bull 3X ETF) and TMV (Direxion Daily 20+ Year Treasury Bear 3X ETF) are both etfs.
But PILL is far broader, holding 73 positions to 9 for TMV, so beyond the top names it adds exposure TMV doesn't have.
TMV is cheaper at 0.97% vs 0.98% — a difference of $1.00 a year per $10,000 invested.
Over five years, TMV returned +25.2% a year vs −12.6% for PILL.
Updated Nov 19, 2026
PILL vs TMV side by side
| PILL | TMV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.98% | 0.97% |
| Annual cost per $10k | $98 | $97 |
| 10-yr cost on $10k (prospectus) | $1,456 | $1,190 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +75.0% | −3.8% |
| 5-yr return (annualized) | −12.6% | +25.2% |
| 10-yr return (annualized) | — | −4.9% |
| Best quarter | +103.7% | +54.0% |
| Worst quarter | −61.4% | −54.7% |
| Net assets (fund) | $20.7M | $193.1M |
| Number of holdings | 73 | 9 |
| Portfolio turnover | 88% | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PILL | TMV | Difference |
|---|---|---|---|
| 2025 | +75.0% | −3.8% | +78.8% |
| 2024 | −6.9% | +39.7% | −46.6% |
| 2023 | −12.7% | −9.7% | −3.0% |
| 2022 | −43.1% | +151.4% | −194.5% |
| 2021 | −37.2% | +0.7% | −37.9% |
| 2020 | −0.3% | −54.3% | +53.9% |
| 2019 | +18.2% | −34.9% | +53.1% |
| 2018 | −19.6% | +5.7% | −25.2% |
Source: Fund prospectus bar charts
Holdings overlap
4 of PILL's top 25 holdings also appear in TMV's top 9.
| Holding | PILL | TMV |
|---|---|---|
| Goldman Financial | 22.36% | 28.82% |
| N/a | 16.36% | 1.22% |
| Dreyfus | 8.14% | 63.18% |
| N/a | 7.41% | 1.22% |
Source: SEC Form N-PORT
PILL top 10
- Goldman Financial — 22.36%
- N/a — 16.36%
- Dreyfus — 8.14%
- N/a — 7.41%
- Crinetics Pharmaceuticals In — 2.77%
- Mbx Biosciences Inc — 2.42%
- Ataibeckley Inc — 2.16%
- Definium Therapeutics, Inc — 2.13%
- Goldman Sachs Liq Es Fd A — 2.03%
- Amylyx Pharmaceuticals Inc — 1.72%
TMV top 10
- Dreyfus — 63.18%
- Goldman Financial — 28.82%
- N/a — 3.60%
- N/a — 3.56%
- Dreyfus — 3.46%
- N/a — 2.85%
- N/a — 2.70%
- N/a — 2.38%
- N/a — 1.22%
FAQ
What is the difference between PILL and TMV?
Which is cheaper, PILL or TMV?
Should I own both PILL and TMV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.